Americas
20 October 2025 The Japanese pharmaceutical company has filed a cluster of lawsuits against generic drug makers asserting its patent protection and market exclusivity over the high-selling ALS treatment.
9 October 2025
7 October 2025
3 October 2025
Latest Features
Americas
In the second of a two-part series, Mercedes Meyer of Banner Witcoff and Brandon Phemester of Novavax delve into the real reasons why medicine costs more in the US.
Americas
Well-drafted contracts and ironclad tech security can save time and money when an ex-employee steals IP ‘like sugar packets in Starbucks’, finds Tom Phillips.
Americas
Being a lawyer with ADHD is far from easy due to widespread misconceptions about the condition but there are ways to offer support, says Lisa Mueller of Casimir Jones.
Americas
Brazil’s updated regulations for its flagship partnerships programme marks a renewed effort to strengthen the nation's health sector, says Rob Rodrigues of RNA Law.
Americas
An ambiguous decision by the Supreme Court has paved the way for frivolous petitions for compensation and clarity is needed, say Daniel Sanchez and Karla Olvera of Olivares.
Americas
Securing IP protection in Brazil for the ‘bio-ink’ used to print new human tissue has challenges but composition is key, say Priscila Kashiwabara and Breno Souza of Kasznar Leonardos.
Americas
If the right steps are taken, the US International Trade Commission is an attractive option for firms fearing the loss of their valuable IP, say Mary Prendergast, Mark Whitaker and Nicole Ang of Morrison Foerster.
Americas
In part 2 of articles assessing the impact of 'Cellect v Samsung', Vincent Shier of Haynes Boone now sets out what the future may hold—both for this unusual case, as well as judicial doctrine in general.
More News
2 October 2025 From stalled drug approvals to suspended patent investigations, US rightsholders face mounting uncertainty during the federal freeze.
2 October 2025 As a US federal shutdown grips IP-critical agencies, layoffs, office closures, and resource cutbacks are underway at the US Patent and Trademark Office.
2 October 2025 As John Squires makes the bold move to allow patentability of an AI-related invention in Ex parte Desjardins, experts broadly welcome the decision—but encourage some caution, finds Sarah Speight.
1 October 2025 Research reveals an increase in global filings in 2024/2025, but concerns remain over the future of vaccine development in the US.
1 October 2025 The healthtech giant has convinced a US court to freeze the assets of two Chinese startups and their ex-employees for breaching an injunction for trade secret theft of X-ray tubes used in CT scanners.
30 September 2025 Duo have a combined 60 years of experience in patent litigation, prosecution, and patent portfolio management across mechanical, electrical, medical devices, chemical and pharmaceutical tech.
29 September 2025 Complaint alleges the pair used Massachusetts company’s patented mRNA TALEN gene-editing technology without permission in multi-billion-dollar cancer therapy deals.
Get up-to-date information on all our publications and events
Get critical life sciences news direct to your inbox